MaveriX Oncology has developed the IMPACT-2X platform for the design of first-in-class small-molecule therapeutics—which are conditionally activated by highly expressed hydroxylases in cancer ...

The immune molecule TGFβ has been found to weaken ... focusing in particular on activated T cells and memory B cells. This choice was informed by vaccination studies, which showed that these ...

Scientists have discovered 'berkelocene,' the first organometallic molecule to be characterized containing the heavy element berkelium. The breakthrough disrupts long-held theories about the ...